{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:05:37Z","timestamp":1791309937705,"version":"4.3.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,7,4]],"date-time":"2011-07-04T00:00:00Z","timestamp":1309737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,7,4]],"date-time":"2011-07-04T00:00:00Z","timestamp":1309737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2012,1,26]]},"DOI":"10.1038\/onc.2011.263","type":"journal-article","created":{"date-parts":[[2011,7,4]],"date-time":"2011-07-04T17:06:27Z","timestamp":1309799187000},"page":"432-445","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":221,"title":["MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1"],"prefix":"10.1038","volume":"31","author":[{"given":"L","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,4]]},"reference":[{"key":"BFonc2011263_CR1","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1172\/JCI38019","volume":"119","author":"H Acloque","year":"2009","unstructured":"Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA . (2009). Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest 119: 1438\u20131449.","journal-title":"J Clin Invest"},{"key":"BFonc2011263_CR2","doi-asserted-by":"publisher","first-page":"9090","DOI":"10.1158\/0008-5472.CAN-09-2552","volume":"69","author":"R Bhattacharya","year":"2009","unstructured":"Bhattacharya R, Nicoloso M, Arvizo R, Wang E, Cortez A, Rossi S et al. (2009). MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. Cancer Res 69: 9090\u20139095.","journal-title":"Cancer Res"},{"key":"BFonc2011263_CR3","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/nm.1880","volume":"14","author":"D Bonci","year":"2008","unstructured":"Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L et al. (2008). The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 14: 1271\u20131277.","journal-title":"Nat Med"},{"key":"BFonc2011263_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1126\/science.1091903","volume":"303","author":"CZ Chen","year":"2004","unstructured":"Chen CZ, Li L, Lodish HF, Bartel DP . (2004). MicroRNAs modulate hematopoietic lineage differentiation. Science 303: 83\u201386.","journal-title":"Science"},{"key":"BFonc2011263_CR5","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.ccr.2011.02.006","volume":"19","author":"J Chen","year":"2011","unstructured":"Chen J, Yao Y, Gong C, Yu F, Su S, Liu B et al. (2011). CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3. Cancer Cell 19: 541\u2013555.","journal-title":"Cancer Cell"},{"key":"BFonc2011263_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ddmec.2008.06.002","volume":"4","author":"KN Chua","year":"2008","unstructured":"Chua KN, Ma J, Thiery JP . (2008). Targeted therapies in control of EMT in carcinoma and fibrosis. Drug Discov Today 4: 261\u2013267.","journal-title":"Drug Discov Today"},{"key":"BFonc2011263_CR7","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1002\/ijc.25522","volume":"128","author":"F Crea","year":"2010","unstructured":"Crea F, Duhagon Serrat MA, Hurt EM, Thomas SB, Danesi R, Farrar WL . (2010). BMI1 silencing enhances docetaxel activity and impairs antioxidant response in prostate cancer. Int J Cancer 128: 1946\u20131954.","journal-title":"Int J Cancer"},{"key":"BFonc2011263_CR8","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1158\/0008-5472.CAN-06-3281","volume":"67","author":"G Feldmann","year":"2007","unstructured":"Feldmann G, Dhara S, Fendrich V, Bedja D, Beaty R, Mullendore M et al. (2007). Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. Cancer Res 67: 2187\u20132196.","journal-title":"Cancer Res"},{"key":"BFonc2011263_CR9","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1200\/JCO.2005.01.057","volume":"23","author":"MK Gibson","year":"2005","unstructured":"Gibson MK, Li Y, Murphy B, Hussain MH, DeConti RC, Ensley J et al. (2005). Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group. J Clin Oncol 23: 3562\u20133567.","journal-title":"J Clin Oncol"},{"key":"BFonc2011263_CR10","doi-asserted-by":"publisher","first-page":"e3148","DOI":"10.1371\/journal.pone.0003148","volume":"3","author":"S Gilad","year":"2008","unstructured":"Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N et al. (2008). Serum microRNAs are promising novel biomarkers. PLoS ONE 3: e3148.","journal-title":"PLoS ONE"},{"key":"BFonc2011263_CR11","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1002\/ijc.23721","volume":"123","author":"EM Gosepath","year":"2008","unstructured":"Gosepath EM, Eckstein N, Hamacher A, Servan K, von Jonquieres G, Lage H et al. (2008). Acquired cisplatin resistance in the head-neck cancer cell line Cal27 is associated with decreased DKK1 expression and can partially be reversed by overexpression of DKK1. Int J Cancer 123: 2013\u20132019.","journal-title":"Int J Cancer"},{"key":"BFonc2011263_CR12","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/ncb1722","volume":"10","author":"PA Gregory","year":"2008","unstructured":"Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G et al. (2008). The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10: 593\u2013601.","journal-title":"Nat Cell Biol"},{"key":"BFonc2011263_CR13","doi-asserted-by":"publisher","first-page":"9628","DOI":"10.1158\/0008-5472.CAN-05-2352","volume":"65","author":"Y Hayashita","year":"2005","unstructured":"Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S et al. (2005). A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65: 9628\u20139632.","journal-title":"Cancer Res"},{"key":"BFonc2011263_CR14","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/ijc.21355","volume":"118","author":"S Hiscox","year":"2006","unstructured":"Hiscox S, Jiang WG, Obermeier K, Taylor K, Morgan L, Burmi R et al. (2006). Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation. Int J Cancer 118: 290\u2013301.","journal-title":"Int J Cancer"},{"key":"BFonc2011263_CR15","doi-asserted-by":"publisher","first-page":"5528","DOI":"10.1158\/0008-5472.CAN-09-4229","volume":"70","author":"Z Jagani","year":"2010","unstructured":"Jagani Z, Wiederschain D, Loo A, He D, Mosher R, Fordjour P et al. (2010). The Polycomb group protein Bmi-1 is essential for the growth of multiple myeloma cells. Cancer Res 70: 5528\u20135538.","journal-title":"Cancer Res"},{"key":"BFonc2011263_CR16","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1517\/14728222.11.8.1119","volume":"11","author":"K Jeyaseelan","year":"2007","unstructured":"Jeyaseelan K, Herath WB, Armugam A . (2007). MicroRNAs as therapeutic targets in human diseases. Expert Opin Ther Targets 11: 1119\u20131129.","journal-title":"Expert Opin Ther Targets"},{"key":"BFonc2011263_CR17","doi-asserted-by":"publisher","first-page":"7559","DOI":"10.1128\/MCB.24.17.7559-7566.2004","volume":"24","author":"M Kajita","year":"2004","unstructured":"Kajita M, McClinic KN, Wade PA . (2004). Aberrant expression of the transcription factors snail and slug alters the response to genotoxic stress. Mol Cell Biol 24: 7559\u20137566.","journal-title":"Mol Cell Biol"},{"key":"BFonc2011263_CR18","first-page":"277","volume":"31","author":"H Kajiyama","year":"2007","unstructured":"Kajiyama H, Shibata K, Terauchi M, Yamashita M, Ino K, Nawa A et al. (2007). Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells. Int J Oncol 31: 277\u2013283.","journal-title":"Int J Oncol"},{"key":"BFonc2011263_CR19","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.breast.2004.02.010","volume":"13","author":"JH Kim","year":"2004","unstructured":"Kim JH, Yoon SY, Jeong SH, Kim SY, Moon SK, Joo JH et al. (2004). Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer. Breast 13: 383\u2013388.","journal-title":"Breast"},{"key":"BFonc2011263_CR20","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nature04303","volume":"438","author":"J Krutzfeldt","year":"2005","unstructured":"Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M et al. (2005). Silencing of microRNAs in vivo with \u2018antagomirs\u2019. Nature 438: 685\u2013689.","journal-title":"Nature"},{"key":"BFonc2011263_CR21","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1002\/stem.154","volume":"27","author":"NK Kurrey","year":"2009","unstructured":"Kurrey NK, Jalgaonkar SP, Joglekar AV, Ghanate AD, Chaskar PD, Doiphode RY et al. (2009). Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells 27: 2059\u20132068.","journal-title":"Stem Cells"},{"key":"BFonc2011263_CR22","doi-asserted-by":"publisher","first-page":"699","DOI":"10.2353\/ajpath.2010.090502","volume":"176","author":"J Li","year":"2010","unstructured":"Li J, Gong LY, Song LB, Jiang LL, Liu LP, Wu J et al. (2010). Oncoprotein Bmi-1 renders apoptotic resistance to glioma cells through activation of the IKK-nuclear factor-kappaB pathway. Am J Pathol 176: 699\u2013709.","journal-title":"Am J Pathol"},{"key":"BFonc2011263_CR23","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1158\/1078-0432.CCR-08-3053","volume":"15","author":"J Li","year":"2009","unstructured":"Li J, Huang H, Sun L, Yang M, Pan C, Chen W et al. (2009a). MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res 15: 3998\u20134008.","journal-title":"Clin Cancer Res"},{"key":"BFonc2011263_CR24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1472-6750-7-36","volume":"7","author":"J Li","year":"2007","unstructured":"Li J, Smyth P, Flavin R, Cahill S, Denning K, Aherne S et al. (2007). Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol 7: 36.","journal-title":"BMC Biotechnol"},{"key":"BFonc2011263_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/cdd.2010.103","volume":"18","author":"QQ Li","year":"2011","unstructured":"Li QQ, Chen ZQ, Cao XX, Xu JD, Xu JW, Chen YY et al. (2011). Involvement of NF-kappaB\/miR-448 regulatory feedback loop in chemotherapy-induced epithelial-mesenchymal transition of breast cancer cells. Cell Death Differ 18: 16\u201325.","journal-title":"Cell Death Differ"},{"key":"BFonc2011263_CR26","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1158\/1078-0432.CCR-08-2372","volume":"15","author":"QQ Li","year":"2009","unstructured":"Li QQ, Xu JD, Wang WJ, Cao XX, Chen Q, Tang F et al. (2009b). Twist1-mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells. Clin Cancer Res 15: 2657\u20132665.","journal-title":"Clin Cancer Res"},{"key":"BFonc2011263_CR27","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1002\/ijc.22891","volume":"121","author":"D Mihic-Probst","year":"2007","unstructured":"Mihic-Probst D, Kuster A, Kilgus S, Bode-Lesniewska B, Ingold-Heppner B, Leung C et al. (2007). Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma. Int J Cancer 121: 1764\u20131770.","journal-title":"Int J Cancer"},{"key":"BFonc2011263_CR28","doi-asserted-by":"publisher","first-page":"29897","DOI":"10.1074\/jbc.M804612200","volume":"283","author":"TE Miller","year":"2008","unstructured":"Miller TE, Ghoshal K, Ramaswamy B, Roy S, Datta J, Shapiro CL et al. (2008). MicroRNA-221\/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J Biol Chem 283: 29897\u201329903.","journal-title":"J Biol Chem"},{"key":"BFonc2011263_CR29","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL et al. (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105: 10513\u201310518.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2011263_CR30","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1158\/1078-0432.CCR-05-0285","volume":"11","author":"P Seve","year":"2005","unstructured":"Seve P, Isaac S, Tredan O, Souquet PJ, Pacheco Y, Perol M . (2005). Expression of class III {beta}-tubulin is predictive of patient outcom. Clin Cancer Res 11: 5481\u20135486.","journal-title":"Clin Cancer Res"},{"key":"BFonc2011263_CR31","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.4161\/cbt.5.11.3458","volume":"5","author":"T Shida","year":"2006","unstructured":"Shida T, Furuya M, Nikaido T, Hasegawa M, Koda K, Oda K et al. (2006). Sonic Hedgehog-Gli1 signaling pathway might become an effective therapeutic target in gastrointestinal neuroendocrine carcinomas. Cancer Biol Ther 5: 1530\u20131538.","journal-title":"Cancer Biol Ther"},{"key":"BFonc2011263_CR32","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1054\/bjoc.2001.2042","volume":"85","author":"E Song","year":"2001","unstructured":"Song E, Chen J, Ouyang N, Su F, Wang M, Heemann U . (2001). Soluble Fas ligand released by colon adenocarcinoma cells induces host lymphocyte apoptosis: an active mode of immune evasion in colon cancer. Br J Cancer 85: 1047\u20131054.","journal-title":"Br J Cancer"},{"key":"BFonc2011263_CR33","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1172\/JCI39374","volume":"119","author":"LB Song","year":"2009","unstructured":"Song LB, Li J, Liao WT, Feng Y, Yu CP, Hu LJ et al. (2009). The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest 119: 3626\u20133636.","journal-title":"J Clin Invest"},{"key":"BFonc2011263_CR34","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY, Nieto MA . (2009). Epithelial-mesenchymal transitions in development and disease. Cell 139: 871\u2013890.","journal-title":"Cell"},{"key":"BFonc2011263_CR35","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s12105-009-0137-y","volume":"3","author":"M Toner","year":"2009","unstructured":"Toner M, O'Regan EM . (2009). Head and neck squamous cell carcinoma in the young: a spectrum or a distinct group? Part 2. Head Neck Pathol 3: 249\u2013251.","journal-title":"Head Neck Pathol"},{"key":"BFonc2011263_CR36","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1158\/0008-5472.CAN-08-4312","volume":"69","author":"Z Wang","year":"2009","unstructured":"Wang Z, Li Y, Kong D, Banerjee S, Ahmad A, Azmi AS et al. (2009). Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway. Cancer Res 69: 2400\u20132407.","journal-title":"Cancer Res"},{"key":"BFonc2011263_CR37","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/ncb1998","volume":"11","author":"U Wellner","year":"2009","unstructured":"Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A et al. (2009). The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 11: 1487\u20131495.","journal-title":"Nat Cell Biol"},{"key":"BFonc2011263_CR38","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/ijc.23501","volume":"123","author":"L Xia","year":"2008","unstructured":"Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun S et al. (2008). miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 123: 372\u2013379.","journal-title":"Int J Cancer"},{"key":"BFonc2011263_CR39","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1158\/0008-5472.CAN-07-3063","volume":"68","author":"K Yamauchi","year":"2008","unstructured":"Yamauchi K, Yang M, Hayashi K, Jiang P, Yamamoto N, Tsuchiya H et al. (2008). Induction of cancer metastasis by cyclophosphamide pretreatment of host mice: an opposite effect of chemotherapy. Cancer Res 68: 516\u2013520.","journal-title":"Cancer Res"},{"key":"BFonc2011263_CR40","doi-asserted-by":"publisher","first-page":"4147","DOI":"10.1158\/1078-0432.CCR-06-0038","volume":"12","author":"AD Yang","year":"2006","unstructured":"Yang AD, Fan F, Camp ER, van Buren G, Liu W, Somcio R et al. (2006). Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Clin Cancer Res 12: 4147\u20134153.","journal-title":"Clin Cancer Res"},{"key":"BFonc2011263_CR41","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/ncb2099","volume":"12","author":"MH Yang","year":"2010","unstructured":"Yang MH, Hsu DS, Wang HW, Wang HJ, Lan HY, Yang WH et al. (2010). Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nat Cell Biol 12: 982\u2013992.","journal-title":"Nat Cell Biol"},{"key":"BFonc2011263_CR42","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1038\/onc.2010.167","volume":"29","author":"F Yu","year":"2010","unstructured":"Yu F, Deng H, Yao H, Liu Q, Su F, Song E . (2010). Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells. Oncogene 29: 4194\u20134204.","journal-title":"Oncogene"},{"key":"BFonc2011263_CR43","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.cell.2007.10.054","volume":"131","author":"F Yu","year":"2007","unstructured":"Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C et al. (2007). let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131: 1109\u20131123.","journal-title":"Cell"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2011263.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2011263","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2011263.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T18:24:26Z","timestamp":1647887066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2011263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,4]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,1,26]]}},"alternative-id":["BFonc2011263"],"URL":"https:\/\/doi.org\/10.1038\/onc.2011.263","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,4]]},"assertion":[{"value":"6 February 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}